Sigma® Life Science launches genetically modified human cell lines for breast cancer research
Expansion of the CompoZr® Oncology Disease Model portfolio...
22 July 2011 | By kdm communications ltd
Expansion of the CompoZr® Oncology Disease Model portfolio...